WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene therapy, and blood product regulation.
“At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” Health and Human Services spokesperson Andrew Nixon told STAT on Saturday.
It is not clear whether he will also still serve as the FDA’s chief medical and scientific officer. Prasad left the agency a mere two weeks ago, after escalating tensions related to a gene therapy product for Duchenne’s muscular dystrophy made by Sarepta Therapeutics and a campaign criticizing Prasad’s politics, launched by right-wing influencer Laura Loomer.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
Source link
